Karandikar NJ - Search Results

1

CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate.

Ratts RB, Lovett-Racke AE, Choy J, Northrop SC, Hussain RZ, Karandikar NJ, Racke MK. Ratts RB, et al. Among authors: karandikar nj. J Neuroimmunol. 2006 Sep;178(1-2):117-29. doi: 10.1016/j.jneuroim.2006.06.001. Epub 2006 Jul 11. J Neuroimmunol. 2006. PMID: 16837065

2

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

Karandikar NJ, Crawford MP, Yan X, Ratts RB, Brenchley JM, Ambrozak DR, Lovett-Racke AE, Frohman EM, Stastny P, Douek DC, Koup RA, Racke MK. Karandikar NJ, et al. J Clin Invest. 2002 Mar;109(5):641-9. doi: 10.1172/JCI14380. J Clin Invest. 2002. PMID: 11877472 Free PMC article.

3

High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.

Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA, Stastny P, Douek DC, Koup RA, Racke MK, Karandikar NJ. Crawford MP, et al. Among authors: karandikar nj. Blood. 2004 Jun 1;103(11):4222-31. doi: 10.1182/blood-2003-11-4025. Epub 2004 Feb 19. Blood. 2004. PMID: 14976054 Free article.

4

Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis.

Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW. Karandikar NJ, et al. Blood. 2004 Oct 1;104(7):2007-9. doi: 10.1182/blood-2004-04-1431. Epub 2004 Jun 17. Blood. 2004. PMID: 15205266 Free article.

5

Glatiramer acetate therapy: the plot thickens.

Karandikar NJ, Racke MK. Karandikar NJ, et al. Arch Neurol. 2005 Jun;62(6):858-9. doi: 10.1001/archneur.62.6.858. Arch Neurol. 2005. PMID: 15956155 No abstract available.

6

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.

Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK. Frohman EM, et al. Arch Neurol. 2005 Sep;62(9):1345-56. doi: 10.1001/archneur.62.9.1345. Arch Neurol. 2005. PMID: 16157741 Review.

7

Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.

Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ. Tennakoon DK, et al. Among authors: karandikar nj. J Immunol. 2006 Jun 1;176(11):7119-29. doi: 10.4049/jimmunol.176.11.7119. J Immunol. 2006. PMID: 16709875

8

Phenotypic characterization of autoreactive T cells in multiple sclerosis.

Ratts RB, Karandikar NJ, Hussain RZ, Choy J, Northrop SC, Lovett-Racke AE, Racke MK. Ratts RB, et al. Among authors: karandikar nj. J Neuroimmunol. 2006 Sep;178(1-2):100-10. doi: 10.1016/j.jneuroim.2006.06.010. Epub 2006 Aug 8. J Neuroimmunol. 2006. PMID: 16901549

9

Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis.

Biegler BW, Yan SX, Ortega SB, Tennakoon DK, Racke MK, Karandikar NJ. Biegler BW, et al. Among authors: karandikar nj. J Neuroimmunol. 2006 Nov;180(1-2):159-71. doi: 10.1016/j.jneuroim.2006.07.015. Epub 2006 Aug 28. J Neuroimmunol. 2006. PMID: 16935352 Clinical Trial.

10

Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.

Pillai V, Lee WM, Thiele DL, Karandikar NJ. Pillai V, et al. Among authors: karandikar nj. J Viral Hepat. 2007 May;14(5):318-29. doi: 10.1111/j.1365-2893.2006.00804.x. J Viral Hepat. 2007. PMID: 17439521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters